A Phase II Study of Tesetaxel in Subjects Previously Treated With Chemotherapy for Metastatic Transitional Cell Carcinoma of the Urothelium.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Tesetaxel (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- Sponsors Genta (CEASED)
- 04 Nov 2011 Planned number of patients changed from 27 to 33 as reported by ClinicalTrials.gov.
- 28 Oct 2010 New source identified and integrated (Memorial Sloan-Kettering Cancer Center).
- 05 Oct 2010 Planned end date (December 2012) added as reported by ClinicalTrials.gov.